ZBNA
RXRX icon

Zions Bancorporation, National Association’s Recursion Pharmaceuticals RXRX Stock Holding History

Zions Bancorporation, National Association’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.98K Hold
540
– – ﹤0.01% 1304
2026
Q1 		$1.66K Buy
+540
New +$2.09K ﹤0.01% 1259

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Zions Bancorporation, National Association's RXRX Position: Q2 2026 in Review

Zions Bancorporation, National Association held its Recursion Pharmaceuticals (RXRX) position steady in Q2 2026 at 540 shares worth $1.98K. The position accounts for ﹤0.01% of the portfolio, ranked #1304.

Zions Bancorporation, National Association first reported a position in RXRX in Q1 2026 and has held it in 2 quarters since. 155 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • Zions Bancorporation, National Association held 540 shares of Recursion Pharmaceuticals worth $1.98K as of Q2 2026.
  • Zions Bancorporation, National Association left its Recursion Pharmaceuticals share count unchanged in Q2 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1304 holding.
  • Zions Bancorporation, National Association first reported a position in Recursion Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 155 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.